Article | February 29, 2024

Three Tips for Achieving Accelerated Drug Discovery And Development

Source: IDBS UK HQ

By Daniel Tabas, Senior Data Scientist, IDBS

Industry 4.0 AI smart factory iStock-1286063951.jpg

Despite a $58 billion investment in technology in 2022, the pharmaceutical industry still relies heavily on outdated manual processes and disorganized data. However, the use of machine learning, artificial intelligence, and advanced analytics is beginning to revolutionize drug discovery and development, potentially bringing drugs to market 500 days faster and 25% cheaper. Alberto Pascual, Director of Data Science & Analytics at IDBS, suggests three key steps to accelerate this process: understanding and managing data effectively, involving scientists in digital transformation, and utilizing advanced analytics. The use of AI and machine learning can further accelerate this process, potentially saving significant time and costs. However, the challenge remains in transferring knowledge from discovery to post-commercialization. Tools like the IDBS Polar platform can securely manage a drug’s progression through its development lifecycle, providing a quality data backbone that is complete, accessible, and reusable.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online